Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Price

Showing results (571-580 of 592) with videos related to

Pageof 60
Sort By:
JMIR Research Protocols|September 9, 2020
Continuity of Care for Patients with Obesity-Associated Chronic Conditions: Protocol for a Multisite Retrospective Cohort StudyYilu Lin, James E Bailey, Satya Surbhi, et al.
The Journal of Prevention of Alzheimer'S Disease|November 6, 2019
Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort StudyC Udeh-Momoh, G Price, M T Ropacki, et al.
Wellcome Open Research|May 7, 2026
The genome sequence of the nematode <i>Ostertagia ostertagi</i> (Stiles, 1892) (Rhabditida, Trichostrongylidae)Daniel R G Price, Yvonne Bartley, Margaret Oliver, et al.
Vaccines|November 24, 2019
A vaccinology Approach to the Identification and Characterization of <i>Dermanyssus Gallinae</i> Candidate Protective Antigens for the Control of Poultry Red Mite InfestationsJosé Francisco Lima-Barbero, Marinela Contreras, Lourdes Mateos-Hernández, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertaseG Beck, G Bottomley, D Bradshaw, et al.
Circulation|February 9, 2021
Effects of a 2-Year Primary Care Lifestyle Intervention on Cardiometabolic Risk Factors: A Cluster-Randomized TrialChristoph Höchsmann, James L Dorling, Corby K Martin, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
A non-vesicular Argonaute protein is transmitted from nematode to mouse and is important for parasite survivalKyriaki Neophytou, Isaac Martínez-Ugalde, Thomas Fenton, et al.
Contemporary Clinical Trials|February 7, 2018
Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL): Rationale, design and baseline characteristicsPeter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
EMBO Reports|December 9, 2025
An Argonaute protein traffics from nematode to mouse and is a vaccine against parasitic nematodesKyriaki Neophytou, Isaac Martínez-Ugalde, Thomas M Fenton, et al.
The New England Journal of Medicine|September 3, 2020
Weight Loss in Underserved Patients - A Cluster-Randomized TrialPeter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
Pageof 60

Showing results (571-580 of 592) with videos related to

Sort By:
Pageof 60
JMIR Research Protocols|September 9, 2020
Continuity of Care for Patients with Obesity-Associated Chronic Conditions: Protocol for a Multisite Retrospective Cohort StudyYilu Lin, James E Bailey, Satya Surbhi, et al.
The Journal of Prevention of Alzheimer'S Disease|November 6, 2019
Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort StudyC Udeh-Momoh, G Price, M T Ropacki, et al.
Wellcome Open Research|May 7, 2026
The genome sequence of the nematode <i>Ostertagia ostertagi</i> (Stiles, 1892) (Rhabditida, Trichostrongylidae)Daniel R G Price, Yvonne Bartley, Margaret Oliver, et al.
Vaccines|November 24, 2019
A vaccinology Approach to the Identification and Characterization of <i>Dermanyssus Gallinae</i> Candidate Protective Antigens for the Control of Poultry Red Mite InfestationsJosé Francisco Lima-Barbero, Marinela Contreras, Lourdes Mateos-Hernández, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertaseG Beck, G Bottomley, D Bradshaw, et al.
Circulation|February 9, 2021
Effects of a 2-Year Primary Care Lifestyle Intervention on Cardiometabolic Risk Factors: A Cluster-Randomized TrialChristoph Höchsmann, James L Dorling, Corby K Martin, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
A non-vesicular Argonaute protein is transmitted from nematode to mouse and is important for parasite survivalKyriaki Neophytou, Isaac Martínez-Ugalde, Thomas Fenton, et al.
Contemporary Clinical Trials|February 7, 2018
Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL): Rationale, design and baseline characteristicsPeter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
EMBO Reports|December 9, 2025
An Argonaute protein traffics from nematode to mouse and is a vaccine against parasitic nematodesKyriaki Neophytou, Isaac Martínez-Ugalde, Thomas M Fenton, et al.
The New England Journal of Medicine|September 3, 2020
Weight Loss in Underserved Patients - A Cluster-Randomized TrialPeter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
Pageof 60